Editor’s Note: The U.S. Transhumanist Party’s Biotechnology Advisor, Dr. Bill Andrews, provides information regarding an innovative effort to fund his longevity research via the new Telomere Coin cryptocurrency. Dr. Andrews has long pursued the goal of lengthening human telomeres and reversing biological aging. The U.S. Transhumanist Party will provide more information regarding the Telomere Coin as it becomes available. The above video was created by the defytime Group. To find out more about defytime and the Telomere Coin, read the whitepaper here. The U.S. Transhumanist Party considers the Telomere Coin to be an Allied Project and looks forward to the results of this innovative approach in raising much-needed funds for the work of Dr. Andrews.
~ Gennady Stolyarov II, Chairman, United States Transhumanist Party, May 8, 2018
Message from Dr. Bill Andrews: The Telomere Coin could be the best opportunity ever to get funding for my research. The Initial Coin Offering (ICO) hasn’t started yet but will in July. But, now there is a pre-sale of the coin underway for investors to buy coins at a lower price. To buy the coins go to http://defytime.groupand click “Go to ICO” and then click on “Join Pre-Sale”.
U.S. Transhumanist Party Discussion Panel on Life Extension – February 18, 2017
For its second expert panel, the U.S. Transhumanist Party invited Bill Andrews, Aubrey de Grey, Ira Pastor, and Ilia Stambler to discuss life extension and the quest to reverse biological aging through science and technology.
This two-hour panel discussion, moderated by Chairman Gennady Stolyarov II, took place on Saturday, February 18, 2017, at 10 a.m. U.S. Pacific Time. In this interactive venue, many opportunities for fresh discourse arose on the possibility of achieving dramatically greater longevity within our lifetimes. The substance of the discussion begins at 4:25 in the recording.
Questions the panelists considered include the following:
(i) How would you characterize the current state of efforts to reverse senescence / lengthen human lifespans? (ii) How does progress in the areas of research you have delved into compare to your expectations approximately 10 to 15 years ago? (iii) What are the most significant challenges and obstacles that you perceive to exist in the way of achieving serious reversal of biological aging? (iv) What key technologies and methods of delivering treatments to patients would need to be developed in order for longevity escape velocity to be affordably achieved society-wide? (v) What political reforms and societal / attitudinal changes would you advocate to accelerate the arrival of effective treatments to reverse biological aging and lengthen lifespans? (vi) Are you concerned about any current political trends and how they might affect the progress of research into combating biological aging? (vii) What can laypersons who are sympathetic to your goals do in order to hasten their realization? How can the effort to defeat aging become as popular and widely supported as efforts to defeat cancer and ALS are today? (viii) What lessons can the history of anti-aging research offer to those who seek to advocate and help achieve effective scientific breakthroughs in this area in the coming years and decades?
Dr. Bill Andrews is the President and CEO of Sierra Sciences – http://www.sierrasci.com/. As a scientist, athlete, and executive, he continually pushes the envelope and challenges convention. In his 35-year biotech career, he has focused the last 23 years on finding ways to extend the human lifespan and healthspan through telomere maintenance. As one of the principal discoverers of both the RNA and protein components of human telomerase, Dr. Andrews was awarded 2nd place as “National Inventor of the Year” in 1997.
Dr. Aubrey de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation – http://www.sens.org/. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.
Ira Pastor has 30 years of experience across multiple sectors of the pharmaceutical industry, including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. He is the CEO of BioQuark, Inc. – http://www.bioquark.com/ – and Executive Chairman of ReAnima Advanced Biosciences – https://reanima.tech/.
Dr. Ilia Stambler is a researcher at Bar Ilan University, Israel. His research focuses on the historical and social implications of aging and life-extension research. He is the author of A History of Life-extensionism in the Twentieth Century – www.longevityhistory.com. He is actively involved in advocacy for aging and longevity research – www.longevityforall.org.